• FAQ
Prophase Logo
open menu
  • About Us
    • About Us
    • Management Team
  • Our Companies
    • Nebula Genomics
    • ProPhase Diagnostics
    • ProPhase Biopharma
    • Pharmaloz Manufacturing
    • TK Supplements
  • Investor Relations
    • Presentations
    • News & Events
      • Press Releases
      • Media Mentions
      • IR Calendar
      • Email Alerts
    • Company Info
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Contact Us
    • Corporate
    • Diagnostics
    • Pharmaloz
    • TKSupplements

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • News & Events
    • Press Releases
    • Media Mentions
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Media Mentions
  • IR Calendar
  • Email Alerts
Nov 04, 2022 8:00am EDT

ProPhase Labs to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time

Oct 19, 2022 8:00am EDT

ProPhase Labs Announces Collaboration with G42 Healthcare

Oct 18, 2022 8:00am EDT

ProPhase Labs to Present at The ThinkEquity Conference

Oct 17, 2022 8:00am EDT

Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.

Sep 06, 2022 8:15am EDT

ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)

Aug 11, 2022 8:00am EDT

ProPhase Labs Announces Record Second Quarter 2022 Financial Results

Aug 04, 2022 8:33pm EDT

ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time

Jul 26, 2022 8:00am EDT

ProPhase Labs Announces New $6 Million Stock Repurchase Plan

Jul 21, 2022 6:00pm EDT

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jul 21, 2022 8:30am EDT

ProPhase Labs Announces Licensing of New Investigational Cancer Compounds

  • arrow_back
  • 1…
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …23
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Prophase Logo

© Copyright - ProPhase Labs, Inc.
All Rights Reserved.

  • About Us
  • Our Companies
  • Investor Relations
  • Contact Us
  • Site Map
  • Legal Notice
  • Accessibility